Severgnini Achille G. → Royalty Pharma plc RPRX

Stake: 8.30% Shares: 36,001,535 CUSIP: G7709Q104 Class: Class A Ordinary Shares, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-07-15

DTC 4.44

12,134,646 shares short · -2.5% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $20.65M

Point72 Asset Mgmt

Post-Filing Returns · since 2025-02-19 on RPRX

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

0.0%

Anchor price 57.80 on closest trading day on/after 2025-02-19. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Royalty Pharma plc

Filed	Form	Filer	Stake	Shares
2026-06-16	SCHEDULE 13D/A	Severgnini Achille G.	—	21,366,927	view →
2022-10-04	SC	Giuliani Mario Germano	—	—	view →

Other Filings by Severgnini Achille G.

Filed	Form	Issuer	Stake	Shares
2026-06-16	SCHEDULE 13D/A	Royalty Pharma plc RPRX	—	21,366,927	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →